Загрузка...
Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers
Vesicular stomatitis virus (VSV) represents an attractive oncolytic virotherapy platform because of its potent tumor cell-killing and immune-stimulating properties; yet the clinical translation of VSV faces numerous challenges, such as inefficient systemic delivery and severe side effects such as ne...
Сохранить в:
| Опубликовано в: : | Mol Ther Oncolytics |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325079/ https://ncbi.nlm.nih.gov/pubmed/30662938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2018.12.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|